| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |